News Breaks |
|
|
| August 3, 2012 |
| 10:02 EDT |  | NUVA, MDT | NuVasive says patent appeal case to be delayed
Medical device maker NuVasive (NUVA) last night disclosed in a regulatory filing that its appeal of a federal court decision on its patent case against Medtronic (MDT) has been delayed. Specifically, a federal appeals court ruled that royalty rates must be determined by a lower court before NuVasive's appeal can proceed, NuVasive reported. The company expects the lower court to reach a decision in the near-term, and it anticipates that the appeal will subsequently move forward. In a note to investors earlier today, Piper Jaffray analyst Matt Miksic wrote that the lower court's final ruling could be a catalyst for NuVasive, as it will remove an overhang on the stock. In early trading, NuVasive added 0.97% to $19.82. |
|
|
News For NUVA;MDT From The Last 14 Days Check below for free stories on NUVA;MDT the last two weeks. |
|
|
| May 22, 2013 |
| 07:48 EDT |  | NUVA, MDT | FDA Orthopaedic and Rehabilitation Devices Panel to hold a meeting
 Subscribe for More Information |
|
| May 21, 2013 |
| 13:02 EDT | | MDT | Medtronic announces CE Mark for CapSureFix Novus
Medtronic announced CE Mark and launch of its CapSureFix Novus 5076 Lead, which is now approved in the EU for use in an MRI environment when paired with a Medtronic MR-Conditional pacemaker. The lead has not been approved for that use in the U.S. |
|
| 11:38 EDT |  | MDT | High option volume stocks: KOS MWE HGG SOL MDT
|
|
| 09:25 EDT | | MDT | On The Fly: Pre-market Movers
Subscribe for More Information |
|
| 07:19 EDT |  | MDT | Medtronic sees FY14 EPS $3.80-$3.85, consensus $3.84
Sees FY14 revenue growth up 3%-4% on a constant currency basis. |
|
| 07:17 EDT | | MDT | Medtronic reports Q4 EPS $1.10, consensus $1.03
Subscribe for More Information |
|
| 05:54 EDT | | MDT | Medtronic announces primary results from Global Symplicity Registry
Subscribe for More Information |
|
| 05:51 EDT | | MDT | Medtronic CoreValue ADVANCE study shows low mortality rates
Subscribe for More Information |
|
| May 20, 2013 |
| 15:53 EDT |  | NUVA | NuVasive removed from Best Ideas List at Barrington
Barrington removed NuVasive from its Best Ideas List due to recent outperformance but reiterates its Outperform rating. |
|
| 15:22 EDT | | MDT | Notable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Home Depot (HD), consensus 77c; Medtronic (MDT), consensus $1.03; The TJX Companies (TJX), consensus 62c; AutoZone (AZO), consensus $7.23; Best Buy (BBY), consensus 25c; Dick's Sporting Goods (DKS), consensus 48c; Tidewater (TDW), consensus 61c; Saks (SKS), consensus 19c; Rexnord (RXN), consensus 31c; Monro Muffler Brake (MNRO), consensus 25c. |
| |
| 09:41 EDT | | MDT | Supreme Court agrees to hear Medtronic-Boston Scientific patent case
Reported by SCOTUSblog live blog of court orders and opinions. |
|
| 07:11 EDT | | MDT | Medtronic receives CE mark for 'export advance' aspiration catheter
Subscribe for More Information |
|
| May 17, 2013 |
| 10:07 EDT |  | NUVA | On The Fly: Analyst Initiation Summary
Subscribe for More Information |
|
| 06:41 EDT | | NUVA | NuVasive initiated with a Buy at WallachBeth
Subscribe for More Information |
|
| May 16, 2013 |
| 13:32 EDT | | MDT | Medtronic volatility flat into Q4 and outlook
Subscribe for More Information |
|
| 10:03 EDT |  | MDT | On The Fly: Analyst Downgrade Summary
Subscribe for More Information |
|
| 06:32 EDT | | MDT | Medtronic downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information |
|
| May 14, 2013 |
| 07:18 EDT | | NUVA | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. |
|
| May 10, 2013 |
| 15:49 EDT | | MDT | Medtronic defibrillators demonstrate success of shock avoidance
Subscribe for More Information |
|
|
|
|
|
